ARCHIVES

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

DCCR Gets Go Ahead For New Community Clinical Oncology Program, $600,000 – $1 Million a Year

May 12, 1978

Carter Request Only $878.8 Million For NCI

January 27, 1978

Prime Contract Subcontract Opportunities

January 24, 1975

NCI Gets Withheld Funds; Hazleton Tops List In Stepped-Up Award Flow

April 4, 1975

Cancer Letter Adds Associate Editor

July 19, 1985

NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives

April 17, 1981